Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Accuracy of Non Invasive Hemoglobin Measure by SpHb Device in Post Operative Anemia Diagnosis
This clinical trial update examines the accuracy of the non-invasive SpHb device for diagnosing postoperative anemia.
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Efficiency of Patient Blood Management Protocol in Gynecological Surgery Department (PERIOPESGYNECO)
Clinical trial update on the PERIOPESGYNECO study evaluating a patient blood management protocol in gynecologic surgery. The trial is NOT_YE…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Small-Volume Tubes to Reduce Anemia and Transfusion [NA]
A completed clinical trial evaluating the use of small-volume blood collection tubes to reduce blood loss-related anemia and transfusion nee…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) [Phase 4]
Phase 4 trial update of the ADIDAS study, examining whether dapagliflozin-related improvements are associated with anemia in patients with h…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors [NA]
Clinical trial update noting the termination of a study evaluating epoetin beta for anemia in patients undergoing chemotherapy for solid tum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock [Phase 3]
A Phase 3 clinical trial evaluating transfusion in patients with hematologic malignancies resuscitated from septic shock has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis [Phase 2]
Phase 2 study evaluating intravenous or subcutaneous sotatercept (ACE-011) in patients with end-stage renal disease on hemodialysis has comp…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Anemia in Systemic Lupus Erythematosus Specially Refractory Type
Clinical trial update indicates a NOT_YET_RECRUITING study sponsored by Assiut University investigating refractory anemia in systemic lupus …
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Effect of Postural Change on Hemoglobin Level in Patients on the Intensive Care Unit [NA]
A ClinicalTrials.gov study is evaluating whether postural changes affect hemoglobin levels in ICU patients with anemia, and the trial is NOT…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease [Phase 4]
A Phase 4 interventional study evaluating the clinical and operational effectiveness of transitioning from Mircera to Daprodustat for the tr…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: School-Based Assessment of Micronutrient Interventions in Adolescents in Burkina Faso [Phase 3]
Phase 3 trial evaluating micronutrient interventions for anemia in adolescents in Burkina Faso has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Myocardial Ischemia and Transfusion [Phase 3]
Phase 3 clinical trial update on transfusion in patients with myocardial infarction and anemia; the Rutgers-sponsored study has completed an…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Potential Harms of Untargeted Iron Supplementation in Cambodia Where Iron Deficiency is Not the Cause of Anemia [Phase 4]
Phase 4 trial assessing safety harms of untargeted iron supplementation in Cambodia where anemia is not caused by iron deficiency; the study…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
This clinical trial update from the Sickle Cell Disease Implementation Consortium outlines the interventions specified for sickle cell disea…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients [Phase 2]
Phase 2 trial evaluated the efficacy and safety of canakinumab for treating anemia in patients with lower-risk myelodysplastic syndromes. Th…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20) [Phase 3]
Phase 3 trial update for epoetin alfa in advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis. [Phase 2]
A phase 2a study evaluated pharmacokinetics, safety, efficacy, tolerability, and pharmacodynamics of sotatercept (ACE-011) for correcting an…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA [Phase 2]
Phase 2 trial comparing avatrombopag alone versus avatrombopag with rhTPO for anemia due to aplastic anemia, focusing on efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Therapeutic Anticoagulation Strategy for Acute Chest Syndrome [Phase 3]
A Phase 3 trial evaluating therapeutic anticoagulation strategy for Acute Chest Syndrome in sickle cell disease.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer [Phase 3]
Phase 3 trial evaluating intravenously administered iron infusion for prevention and treatment of anemia in ovarian cancer.
-
EMA withdrawal · 2023-12-13EMA Application withdrawn: Jesduvroq (daprodustat) — GlaxoSmithKline Trading Services Limited
The EMA has withdrawn the marketing authorization application for Jesduvroq (daprodustat) by GlaxoSmithKline Trading Services Limited.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding [Phase 4]
Phase 4 trial comparing IV iron to oral iron for anemia in women with abnormal uterine bleeding; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update testing sotatercept for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer. The study was…
-
EMA withdrawal · 2023-09-29EMA Revoked: Adakveo (Crizanlizumab) — Novartis Europharm Limited
EMA has revoked Adakveo (crizanlizumab) marketed by Novartis Europharm Limited for sickle cell disease/anemia.
-
EMA approval · 2023-09-27EMA Authorised: Eporatio (epoetin theta) — Ratiopharm GmbH
Authorised status for Eporatio (epoetin theta) by Ratiopharm GmbH for treatment areas including chronic kidney failure, anemia, and cancer.